Statins for primary prevention of cardiovascular disease

BMJ. 2019 Oct 16:367:l5674. doi: 10.1136/bmj.l5674.
No abstract available

MeSH terms

  • Attitude of Health Personnel
  • Cardiovascular Diseases / prevention & control*
  • Decision Making*
  • Eligibility Determination
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / administration & dosage
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / adverse effects
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / economics
  • Patient Preference
  • Patient Selection
  • Practice Guidelines as Topic
  • Primary Prevention / methods*
  • Risk Assessment*

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors